Aurelie Hatton

An unexpected effect of TNF-α on F508del-CFTR maturation and function.

Analysis of nasal potential in murine cystic fibrosis models.

Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons.

Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?

Predictive factors for lumacaftor/ivacaftor clinical response.

Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis.

Author Correction: Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis.

New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation.

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation.

Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators.

Author Correction: New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation.

Correlating genotype with phenotype using CFTR-mediated whole-cell Cl currents in human nasal epithelial cells.

Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis. Moving forward.

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice.